Literature DB >> 8420935

The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles.

A Jonas1, A Steinmetz, L Churgay.   

Abstract

The objective of this work was to determine the role of the amphipathic alpha-helical structural units of human apolipoproteins A-I, E, and A-IV in defining the sizes and reactivities with lecithin:cholesterol acyltransferase (LCAT) of their reconstituted lipoprotein particles. We prepared reconstituted high density lipoprotein (rHDL) particles with each of the three apolipoproteins in two weight ratios with lipid: 2.7/0.07/1 and 1.35/0.04/1, palmitoyloleoylphosphatidylcholine/cholesterol/apolipoprotein, by the sodium cholate dialysis procedure; and examined the rHDL product sizes and distributions by nondenaturing gradient gel electrophoresis. The rHDL particles were also incubated with low density lipoprotein (LDL), and with LDL plus LCAT, to observe any structural modifications due to phospholipid transfers to LDL and to cholesterol esterification by LCAT. In addition, we examined the average structural properties of the original rHDL by several fluorescence methods and circular dichroism spectroscopy, and determined their reaction kinetics with LCAT. The results indicate that the diameters of the largest rHDL particles, containing two apolipoproteins per particle, correlate with the maximum number of putative amphipathic alpha-helical segments in their sequences, and that smaller particles of this class may arise from the removal of one or more alpha-helical segments from contact with lipid. Furthermore, the larger particles may be converted into the smaller ones upon loss of phospholipid to LDL, and may form one or two well defined products when reacted with LCAT. In general, the subclasses of particles have distinct spectroscopic properties, consistent with a different apolipoprotein folding in particles containing different proportions of phospholipid to apolipoprotein. Furthermore, the different apolipoprotein structures lead to significant differences in reactivity with LCAT.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420935

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Method to Visualize and Analyze Membrane Interacting Proteins by Transmission Electron Microscopy.

Authors:  Ramakrishnan B Kumar; Lin Zhu; Hans Hebert; Caroline Jegerschöld
Journal:  J Vis Exp       Date:  2017-03-05       Impact factor: 1.355

Review 2.  Nanodiscs in Membrane Biochemistry and Biophysics.

Authors:  Ilia G Denisov; Stephen G Sligar
Journal:  Chem Rev       Date:  2017-02-08       Impact factor: 60.622

3.  Synthetic amphipathic helical peptides that mimic apolipoprotein A-I in clearing cellular cholesterol.

Authors:  A J Mendez; G M Anantharamaiah; J P Segrest; J F Oram
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Mass spectrometric determination of apolipoprotein molecular stoichiometry in reconstituted high density lipoprotein particles.

Authors:  John B Massey; Henry J Pownall; Stephen Macha; Jamie Morris; Matthew R Tubb; R A Gangani D Silva
Journal:  J Lipid Res       Date:  2009-01-28       Impact factor: 5.922

5.  The structure of human apolipoprotein A-IV as revealed by stable isotope-assisted cross-linking, molecular dynamics, and small angle x-ray scattering.

Authors:  Ryan G Walker; Xiaodi Deng; John T Melchior; Jamie Morris; Patrick Tso; Martin K Jones; Jere P Segrest; Thomas B Thompson; W Sean Davidson
Journal:  J Biol Chem       Date:  2014-01-14       Impact factor: 5.157

6.  Dynamics of activation of lecithin:cholesterol acyltransferase by apolipoprotein A-I.

Authors:  Martin K Jones; Andrea Catte; Ling Li; Jere P Segrest
Journal:  Biochemistry       Date:  2009-12-01       Impact factor: 3.162

7.  A three-dimensional homology model of lipid-free apolipoprotein A-IV using cross-linking and mass spectrometry.

Authors:  Matthew R Tubb; R A Gangani D Silva; Jianwen Fang; Patrick Tso; W Sean Davidson
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

8.  Analysis of lipid transfer activity between model nascent HDL particles and plasma lipoproteins: implications for current concepts of nascent HDL maturation and genesis.

Authors:  Dana Bailey; Isabelle Ruel; Anouar Hafiane; Haley Cochrane; Iulia Iatan; Matti Jauhiainen; Christian Ehnholm; Larbi Krimbou; Jacques Genest
Journal:  J Lipid Res       Date:  2009-09-29       Impact factor: 5.922

9.  Harnessing a physiologic mechanism for siRNA delivery with mimetic lipoprotein particles.

Authors:  Tomoko Nakayama; James S Butler; Alfica Sehgal; Mariano Severgnini; Tim Racie; Jennifer Sharman; Feng Ding; Svetlana Shulga Morskaya; Joshua Brodsky; Lubomir Tchangov; Verbena Kosovrasti; Mike Meys; Lubomir Nechev; Gang Wang; Chang Geng Peng; Yupang Fang; Martin Maier; Kallanthottathil G Rajeev; Robert Li; Julia Hettinger; Scott Barros; Valerie Clausen; Xuemei Zhang; Qianfan Wang; Renta Hutabarat; Nikolay V Dokholyan; Christian Wolfrum; Muthiah Manoharan; Victor Kotelianski; Markus Stoffel; Dinah Wy Sah
Journal:  Mol Ther       Date:  2012-06-05       Impact factor: 11.454

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.